Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivo.
about
CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for NeuroprotectionLongitudinal testing of hippocampal plasticity reveals the onset and maintenance of endogenous human Aß-induced synaptic dysfunction in individual freely behaving pre-plaque transgenic rats: rapid reversal by anti-Aß agents.Intrinsic excitability changes induced by acute treatment of hippocampal CA1 pyramidal neurons with exogenous amyloid β peptide.Structure-dependent effects of amyloid-β on long-term memory in Lymnaea stagnalis.Amyloid Oligomers and Mature Fibrils Prepared from an Innocuous Protein Cause Diverging Cellular Death Mechanisms.Synaptic plasticity in health and disease: introduction and overview.
P2860
Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neurotransmitter receptor and ...... lzheimer's disease Aβ in vivo.
@en
Neurotransmitter receptor and ...... lzheimer's disease Aβ in vivo.
@nl
type
label
Neurotransmitter receptor and ...... lzheimer's disease Aβ in vivo.
@en
Neurotransmitter receptor and ...... lzheimer's disease Aβ in vivo.
@nl
prefLabel
Neurotransmitter receptor and ...... lzheimer's disease Aβ in vivo.
@en
Neurotransmitter receptor and ...... lzheimer's disease Aβ in vivo.
@nl
P2093
P2860
P356
P1476
Neurotransmitter receptor and ...... Alzheimer's disease Aβ in vivo
@en
P2093
Dominic M Walsh
Igor Klyubin
Jennifer Hayes
Tomas Ondrejcak
William K Cullen
P2860
P304
P356
10.1098/RSTB.2013.0147
P407
P577
2013-12-02T00:00:00Z